Weight-loss drug awaiting FDA approval combines antidepressant, addiction medications

June 11, 2014 by Stasia Thompson

On Wednesday, June 11, a new prescription weight-loss medication that combines a popular antidepressant with a medication for addiction will be reviewed by the Federal Drug Administration (FDA) for potential approval.

Losing and keeping it off is not as easy as simply popping the right pill, but medications can be a part of a healthy diet, said an internationally recognized weight-loss specialist.

"Prescription drugs are no substitute for low-fat, high-fiber balanced diets coupled with , but medication can help increase weight loss in some people," said Bipan Chand, MD, FACS, FASMBS, FASGE, director of the Loyola Center for Metabolic Surgery & Bariatric Care.

Americans spend an estimated $20 billion annually on weight-loss products, including medications.

The new prescription medication is a combination of two FDA-approved drugs, bupropion, an antidepressant, and naltrexone, which reduces the desire for drugs and alcohol. Both have been found to increase weight loss in independent research trials and combining the two in one capsule is believed to create a synergistic effect. In clinical trials, patients taking the new medication while following a diet and exercise program lost more weight than those taking a placebo and following the same diet and exercise regimen.

In a 56-week period, the nonmedicated group lost 11-16 pounds while the medicated patients lost 20- 23 pounds.

In February 2011, the FDA requested a large-scale study of the long-term cardiovascular effects of the drug before considering approval.

"Many medications for various conditions have been found to have weight loss as a side effect, and conversely, many medications can cause weight gain," Chand said. Weight-loss medications commonly involve an appetite suppressant and a metabolism booster. But not all patients can tolerate prescription weight-loss medication.

"Many obese patients are on medication for chronic conditions, such as heart disease, high blood pressure, high cholesterol, depression and diabetes," Chand said. "Adding another medication must be carefully assessed to make sure it has a positive and not a negative effect on the patient's health."

More than two-thirds of American adults are overweight or obese and 1 in 3 American children and teens are considered obese.

"Behavioral therapy, nutrition counseling, physical exercise and as well as medication are all instruments in the weight-loss toolbox," said Chand, who is a board-certified metabolic surgeon at Loyola, an accredited Level 1 facility under the Bariatric Surgery Center Network (BSCN) Accreditation Program of the American College of Surgeons (ACS).

"Bariatric surgery has been the most effective tool in achieving long-term weight loss, which leads to overall improvement in health, reducing or eliminating chronic conditions and medications and increasing years of life," said Chand, who performs bariatric surgeries.

"At Loyola, we treat obesity as a complex disease and design a treatment solution tailored to each patient," Chand said. "Medication may be prescribed but so is meeting with a dietitian to design a better diet, attending support groups for education and encouragement, working with an exercise physiologist to get moving, seeing an internal medicine physician for overall health assessment and monitoring and potentially scheduling for a more permanent solution," Chand said. "Many Loyola weight-loss patients succeed with medication or surgery and many succeed without medication or surgery. Our medical team of board-certified bariatric professionals work together with the patient to find the right solution."

Since opening on July 10, 2012, at Loyola's Melrose Park campus, a multidisciplinary team of bariatric-certified professionals, including surgeons, psychologists, dietitians, exercise physiologists and physicians has cared for hundreds of morbidly obese men, women and children.

Surgical procedures offered by Loyola include laparoscopic adjustable gastric banding, Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy.

The Loyola Center for Metabolic Surgery & Bariatric Care underwent a voluntary evaluation conducted by an independent team of experienced bariatric surgeons. Loyola was deemed to meet the rigorous, nationally recognized standards outlined by the BSCN ACS for:

  • Safety of the bariatric surgery patient
  • Documented, quality surgical outcomes
  • Standards of practice
  • Highly trained and experienced medical professionals
  • Specially designed facilities to accommodate obese patients and their families
  • Comprehensive medical, nutritional and psychological support throughout the treatment process

Explore further: New report cites link between alcohol abuse and bariatric surgery

Related Stories

New report cites link between alcohol abuse and bariatric surgery

June 25, 2012
An addiction to food may be replaced by an addiction to alcohol in certain bariatric patients. According to a new study in the Journal of the American Medical Association, having Roux-en-Y gastric bypass surgery, where the ...

Weight loss surgery also safeguards obese people against cancer

June 4, 2014
Weight loss surgery might have more value than simply helping morbidly obese people to shed unhealthy extra pounds. It reduces their risk of cancer to rates almost similar to those of people of normal weight. This is the ...

Study exposes risk of nutritional deficiencies in obese teens

May 4, 2014
A new study exposes the risk of nutritional deficiencies in severely obese teens – both those who had weight loss surgery and those who did not.

Lap band surgery helps combat diabetes

September 2, 2013
(Medical Xpress)—A trial of gastric band surgery in overweight people with type 2 diabetes has found the surgery resulted in better outcomes for diabetes and weight loss than standard exercise and diet plans.

Two JAMA Surgery studies examine bariatric surgery for type 2 diabetes treatment

June 4, 2014
Roux-en-Y gastric bypass surgery resulted in the greatest average weight and appears to be the best treatment for type 2 diabetes mellitus (T2DM) compared to gastric banding and lifestyle intervention in a clinical trial ...

Body contouring improves long-term weight control after gastric bypass

October 1, 2013
Body contouring surgery to remove excess skin improves long-term weight control in patients after gastric bypass surgery, reports a study in the October issue of Plastic and Reconstructive Surgery, the official medical journal ...

Recommended for you

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

At-risk chronic pain patients taper opioids successfully with psychological tools

June 28, 2017
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

JamesG
not rated yet Jun 11, 2014
20 - 23 pounds in 56 weeks while following a diet and exercise program. That's pretty slow weight loss for over a year and not the slightest bit encouraging to someone who needs to lose 200 lbs or more. This is just big pharma and Loyola University trying to sell a product.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.